Click Therapeutics Overview
- Year Founded
-
2012

- Status
-
Private
- Employees
-
192

- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$11.3M
- Investors
-
14
Click Therapeutics General Information
Description
Developer of software as medical treatments prescription platform designed to deliver safe and effective digital treatments to patients in need. The company's software personalizes user experience to drive cognitive and behavioral outcomes, enabling the medical community to optimally treat people with brain disorders and neuro-psychiatric dysfunction.
Contact Information
Website
www.clicktherapeutics.comCorporate Office
- 80 White Street
- 3rd Floor
- New York, NY 10013
- United States
Corporate Office
- 80 White Street
- 3rd Floor
- New York, NY 10013
- United States
Click Therapeutics Timeline
Click Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
13. Later Stage VC | 21-Nov-2024 | $11.3M | Completed | Generating Revenue | ||
12. Debt Refinancing | 06-Nov-2023 | Completed | Generating Revenue | |||
11. Debt Refinancing | 15-Apr-2022 | Completed | Generating Revenue | |||
10. Later Stage VC (Series B) | 22-Oct-2021 | Completed | Generating Revenue | |||
9. Debt - General | 01-Dec-2020 | Completed | Generating Revenue | |||
8. Debt - PPP | 11-Apr-2020 | Completed | Generating Revenue | |||
7. Later Stage VC | 03-Jan-2019 | Completed | Generating Revenue | |||
6. Later Stage VC (Series A) | 01-Oct-2018 | Completed | Generating Revenue | |||
5. Later Stage VC | 18-Apr-2017 | $3.69M | $7.62M | Completed | Generating Revenue | |
4. Early Stage VC | 18-Apr-2016 | $805K | $3.93M | Completed | Generating Revenue |
Click Therapeutics Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B | ||||||||
Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Click Therapeutics Comparisons
Industry
Financing
Details
Click Therapeutics Competitors (28)
One of Click Therapeutics’s 28 competitors is Vivify Health, a Formerly VC-backed company based in Plano, TX.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Vivify Health | Formerly VC-backed | Plano, TX | ||||
Orbita | Venture Capital-Backed | Boston, MA | ||||
Cognoa | Venture Capital-Backed | Palo Alto, CA | ||||
AMC Health | Private Equity-Backed | New York, NY | ||||
Cecelia Health | Venture Capital-Backed | New York, NY |
Click Therapeutics Patents
Click Therapeutics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-12040063-B1 | Systems and methods for regulating provision of messages with content from disparate sources based on risk and feedback data | Active | 09-Oct-2023 | ||
US-12106860-B1 | Systems and methods for regulating provision of messages with content from disparate sources based on risk and feedback data | Active | 09-Oct-2023 | ||
US-12057238-B1 | Targeted generation of messages for digital therapeutics using generative transformer models | Active | 28-Sep-2023 | ||
EP-4503048-A1 | Presenting multimodal, multistable stimuli to reduce symptoms associated with attention biases due to impairment of cognitive functions in users | Pending | 03-Aug-2023 | ||
US-20250041554-A1 | Presenting multimodal, multistable stimuli to reduce symptoms associated with attention biases due to impairment of cognitive functions in users | Pending | 03-Aug-2023 | A61M21/00 |
Click Therapeutics Signals
Click Therapeutics Investors (14)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Accelmed | Growth/Expansion | Minority | ||
Health Catalyst Capital Management | Growth/Expansion | Minority | ||
H.I.G. HealthBridge Partners | Venture Capital | Minority | ||
Revelation Partners | Venture Capital | Minority | ||
Ridgetop Health | Corporation | Minority |
Click Therapeutics Investments (1)
Click Therapeutics’s most recent deal was a Corporate Asset Purchase with Better Therapeutics (Digital Therapeutics for Obesity and Cardiometabolic Disease Assets). The deal was made on 22-May-2024.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Better Therapeutics (Digital Therapeutics for Obesity and Cardiometabolic Disease Assets) | 22-May-2024 | Corporate Asset Purchase | Buildings and Property |
Click Therapeutics FAQs
-
When was Click Therapeutics founded?
Click Therapeutics was founded in 2012.
-
Where is Click Therapeutics headquartered?
Click Therapeutics is headquartered in New York, NY.
-
What is the size of Click Therapeutics?
Click Therapeutics has 192 total employees.
-
What industry is Click Therapeutics in?
Click Therapeutics’s primary industry is Drug Discovery.
-
Is Click Therapeutics a private or public company?
Click Therapeutics is a Private company.
-
What is Click Therapeutics’s current revenue?
The current revenue for Click Therapeutics is
. -
How much funding has Click Therapeutics raised over time?
Click Therapeutics has raised $168M.
-
Who are Click Therapeutics’s investors?
Accelmed, Health Catalyst Capital Management, H.I.G. HealthBridge Partners, Revelation Partners, and Ridgetop Health are 5 of 14 investors who have invested in Click Therapeutics.
-
Who are Click Therapeutics’s competitors?
Vivify Health, Orbita, Cognoa, AMC Health, and Cecelia Health are some of the 28 competitors of Click Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »